Motilium Fastmelts Domperidone 10mg Tablets For Nausea and Vomiting 10 Pack

Motilium Tablets contain Domepridone and should be used at the lowest effective dose for the shortest duration necessary to control nausea and vomiting.

• Take one tablet before meals up to three times in a day
• Do not exceed three tablets in a 24 hour period
• Take each dose at the scheduled time. If a scheduled dose is missed, the missed dose should be omitted and the usual dosing schedule resumed. The dose should not be doubled to make up for a missed dose
• Treatment should not exceed one week. Consult your doctor if symptoms have not improved
• Treatment with domperidone should be stopped if signs or symptoms occur that may be associated with cardiac arrhythmia- Consult your doctor
• Promptly report any cardiac symptoms

Special Warnings

Do not take Motilum Fastmelt Tablets if any of the following apply

• Hypersensitivity to the active substance or to any of the excipients listed in the patient leaflet
• Prolactin-releasing pituitary tumour (prolactinoma)
• If stimulation of the gastric motility could be harmful, e.g., in patients with gastro-intestinal haemorrhage, mechanical obstruction or perforation
• Moderate or severe hepatic impairment
• Known existing prolongation of cardiac conduction intervals, particularly QTc, patients with significant electrolyte disturbances or underlying cardiac diseases such as congestive heart failure
• If you are taking QT-prolonging medicinal products, with the exception of apomorphine (see section below or SPC for further details)
• If you are taking potent CYP3A4 inhibitors (see section below or SPC for further details)

Interaction with other medicines

• When antacids or antisecretory medicinal products are used concomitantly, they should be taken after meals and not before meals
• Co-administration with levodopa: An increase of up to 30-40% in plasma concentrations of levodopa has been observed when taking along with domperidone

Each Motilium Fastmelt Tablet contains Domperidone 10mg

Gelatin, mannitol (E421), aspartame (E951), mint flavoring, poloxamer 188

Motilium Fastmelt Tablets Patient Information Leaflet?